Compare
Taltz vs. Bimzelx

Taltz (ixekizumab) is an injection that's given under the skin. It helps treat inflammatory conditions, including plaque psoriasis, psoriatic arthritis, and some types of arthritis in the spine. This medication works as an interleukin antagonist to lessen inflammation in the body. You inject Taltz (ixekizumab) once a month using the prefilled syringe or autoinjector. The dose depends on the health problem you're treating. Side effects include upper respiratory infections. You also might feel pain or have redness around the injection area. Taltz (ixekizumab) is a brand-name medication.

• Moderate-to-severe plaque psoriasis in people 6 years and older
• Psoriatic arthritis in adults
• Ankylosing spondylitis in adults
• Non-radiographic axial spondyloarthritis in adults

• Reaction at the injection site (e.g., redness, pain; 17%)
• Upper respiratory tract infections (14%)

• Risk of infection
• Caution when getting vaccines
• Eczema-like skin reaction
• Allergic reaction
• Inflammatory bowel disease

Bimzelx (bimekizumab or bimekizumab-bkzx) is an injection that's used to treat several inflammatory conditions in adults. They include plaque psoriasis, psoriatic arthritis, and hidradenitis suppurativa, to name a few. It's a type of monoclonal antibody called an interleukin antagonist. It works to reduce inflammation in the body. Bimzelx (bimekizumab) comes in prefilled autoinjectors or prefilled syringes. You inject the medication under the skin either every month or every other month. It can cause side effects like upper respiratory infections.

• Moderate-to-severe plaque psoriasis
• Psoriatic arthritis
• Non-radiographic axial spondyloarthritis
• Ankylosing spondylitis
• Moderate-to-severe hidradenitis suppurativa

• Upper respiratory tract infection (runny nose, sore throat; 15%)
• Oral thrush (9%)
• Headache (3%)
• Injection site reactions (redness, pain, swelling, bruising; 3%)
• Fungal skin infections (3%)

• Suicidal thoughts or behavior
• Risk of infections
• Liver problems
• Inflammatory bowel disease
• Interaction with vaccines